Media

Media

Welcome to Beximco Pharma’s news and media center. Here in the media center you will find a range of resources including our latest and archived news releases, publication and information on our official social media, and multimedia gallery where our photo and video library.

News

We are welcoming you to the News section of our website. We categorize this News section into three parts so that you can easily find your necessary information as well as your quest.

 Read More

Multimedia Gallery

Multimedia Gallery is composed of audio visual library, photos and audio documents of Beximco Pharma Ltd.

 Read More

Social Media

Beximco Pharma page delivers various news and features of company like social responsibility, new product launching and events.

 Read More

Latest News

Latest News

 

Beximco Pharmaceuticals Limited (“BPL” or “Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients.

 Read More

New Product Update

New Product Update

 

Beximco Pharmaceuticals Limited launched new products

 Read More

Investors′ Update

Investors′ Update

 

Investors′ Update for Beximco Pharmaceuticals Limited

 Read More

Historic Events

Historic Events

 

Historic Events for Beximco Pharmaceuticals Limited

 Read More

Video Gallery

Video Gallery

It is the Youtube channel of BPL where important videos such as surgical, manufacturing process etc are uploaded. Viewers can post comments and opinions as compliments so that we can develop our channel.

 Read More

Image Gallery

Image Gallery

This segment of media is the store house of photographs of BPL such as photos of products, new product launching, manufacturing process, factory premises etc. Image gallery will reconcile your visual pleasure as the company at its best!

 Read More

Audio Gallery

Audio Gallery

Here various kinds of audio files are stored which are contained of important topics. You can find doctors suggestions about various diseases as well as BPL′s development towards pharmaceutical arena.

 Read More